Thora Sigmarsdottir

Mrs. Thora Sigmarsdottir


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 December 2021 in Bioengineering
Verified
Journal Article
Open access
PDF file
TSThora Sigmarsdottir
Thora Sigmarsdottir
SMSarah McGarrity
Sarah McGarrity
Adrian Lopez Garcia de LomanaAdrian Lopez Garcia de Lomana
Adrian Lopez Garcia de Lomana
AKAristotelis Kotronoulas
Aristotelis Kotronoulas
SSSnaevar Sigurdsson
Snaevar Sigurdsson
Ólafur SigurjónssonÓlafur Sigurjónsson
Ólafur Sigurjónsson
Mesenchymal stromal cells (MSCs) are multipotent post-natal stem cells with applications in tissue engineering and regenerative medicine. MSCs can differentiate into osteoblasts, chondrocytes, or adipocytes, with functional differences in cells during osteogenesis accompanied by metabolic changes. The temporal dynamics of these metabolic shifts have not yet been fully characterized and are suspected to be important for therapeutic applications such as osteogenesis optimization. Here, our goal was to characterize the metabolic shifts that occur during osteogenesis. We profiled five key extracellular metabolites longitudinally (glucose, lactate, glutamine, glutamate, and ammonia) from MSCs from four donors to classify osteogenic differentiation into three metabolic stages, defined by changes in the uptake and secretion rates of the metabolites in cell culture media. We used a combination of untargeted metabolomic analysis, targeted analysis of 13C-glucose labelled intracellular data, and RNA-sequencing data to reconstruct a gene regulatory network and further characterize cellular metabolism. The metabolic stages identified in this proof-of-concept study provide a framework for more detailed investigations aimed at identifying biomarkers of osteogenic differentiation and small molecule interventions to optimize MSC differentiation for clinical applications.